Newsroom – Insights,  Announcements & Recognition

Stay up to date with Cyntegrity’s latest company news, industry and product updates,  speaking engagements, and media appearances.

Newsroom – Insights, Events & Recognition

Stay up to date with Cyntegrity’s latest company news, industry and product updates,  speaking engagements, and media appearances.

Upcoming Events

Stay up to date with upcoming events, including new training sessions, webinars and workshops.

9 June 2026

mindsON RBQM Special Edition webinar | “Clinical R&D Due Diligence: Detecting Execution Risk, Data Integrity Issues, and Hidden Misconduct Signals” with Cyntegrity’s CEO & Founder, Artem Andrianov, and Shenaz Vakharia, VP, APAC at ADAMAS Consulting.
Register for free here…

17 June 2026

mindsON RBQM webinar | “Why do people still think 100% SDV is gold standard quality?” with Cyntegrity’s Chief Scientific Officer, Dr. Johann Proeve, and RBQM SME Keith Dorricott, MBB.
Register for free here…

24 June 2026

actON QbD webinar | “Inside Central Monitoring: A Hands-On RBQM Simulation” with RBQM SME Keith Dorricott, MBB, and Cyntegrity’s Head of Growth, Julien Goncalves.
Register for free here…

Tamara Beck

Operations Manager, MyRBQM® Academy & Event Coordinator

Get in touch with Tamara for event details, co-speaking opportunities, or to connect with our alumni community.

academy@cyntegrity.com

Phone Number

+49 (0) 6192 470 113 50

Website

academy.cyntegrity.com

Stay Informed with Us

News & Insights

Industry Recognitions

Product Updates

Events

AI Literacy in Clinical Trials Under ICH E6(R3)

AI-supported workflows in clinical trials increasingly fall within GCP, computerized system, data integrity, and AI governance expectations. Sponsors and CROs need teams that understand oversight, validation, accountability, and responsible AI use....

11 May 2026
1:53 PM

FDA Warning Letter Highlights AI Oversight Risks in Clinical Trials

FDA’s warning letter signals a shift: AI use without oversight is a compliance risk. What clinical trial teams must understand to stay inspection-ready....

24 April 2026
2:23 PM

Milestone | We Have Just Received our ISO 9001:2015 Certificate

Cyntegrity is now ISO 9001:2015 certified. Learn how this strengthens quality governance, continuous improvement, and trust in AI-augmented RBQM solutions. ...

12 November 2025
2:45 PM

Microsoft-Certified AI in Healthcare

MyRBQM® Portal is now Microsoft-Certified Healthcare AI. Learn how this strengthens trust, validation, and transparency in AI-supported clinical oversight. ...

11 November 2025
2:01 PM

Service Level Availability – SLA

Service Level Availability or “SLA” means the targeted availability levels measured in the Production environment, as specified in the SaaS Listing which may vary according to each SaaS Offering and its component capabilities....

12 May 2026
12:15 PM

From spreadsheets to Digital RACT | ICH E6(R3) compliance

Learn why spreadsheet-based RACT falls short of ICH E6(R3) and how Digital RACT in the MyRBQM Portal delivers traceable, inspection-ready risk governance....

9 February 2026
11:46 AM

It seems we can’t find what you’re looking for.

Article Title

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip …

The Real Cost of Trial Delays & How RBQM Reduces Risk

Clinical trial delays are costly. Learn updated cost estimates and how RBQM + QbD make studies more predictable, efficient, and patient-focused.

Media Inquiries

Need a quote, speaker, or more info about Cyntegrity? Reach out directly to our media contact for timely assistance.

Newsroom – Insights,  Announcements & Recognition

Newsroom – Insights, Events & Recognition

Upcoming Events

Tamara Beck

Operations Manager, MyRBQM® Academy & Event Coordinator

Stay Informed with Us

AI Literacy in Clinical Trials Under ICH E6(R3)

FDA Warning Letter Highlights AI Oversight Risks in Clinical Trials

Milestone | We Have Just Received our ISO 9001:2015 Certificate

Microsoft-Certified AI in Healthcare

Service Level Availability – SLA

From spreadsheets to Digital RACT | ICH E6(R3) compliance

Article Title

The Real Cost of Trial Delays & How RBQM Reduces Risk

Media Inquiries

+49 (0) 6192 470 113.50 (Europe)

+1 (0) 888 812 RBQM (USA)

Newsroom – Insights, Announcements & Recognition

Newsroom – Insights, Events & Recognition

Upcoming Events

Tamara Beck

Operations Manager, MyRBQM® Academy & Event Coordinator

Stay Informed with Us

AI Literacy in Clinical Trials Under ICH E6(R3)

FDA Warning Letter Highlights AI Oversight Risks in Clinical Trials

Milestone | We Have Just Received our ISO 9001:2015 Certificate

Microsoft-Certified AI in Healthcare

Service Level Availability – SLA

From spreadsheets to Digital RACT | ICH E6(R3) compliance

Article Title

The Real Cost of Trial Delays & How RBQM Reduces Risk

Media Inquiries

+49 (0) 6192 470 113.50 (Europe)

+1 (0) 888 812 RBQM (USA)

AI Use in Clinical Trials Is Increasing. So Are Regulatory Expectations.

Regulators expect controlled, documented, and reviewable AI use. Prepare your teams to apply AI within GCP and computerized system requirements.

Newsroom – Insights,  Announcements & Recognition

Newsroom – Insights, Events & Recognition

AI Use in Clinical Trials Is Increasing.
So Are Regulatory Expectations.